Bausch & Lomb announced this week that former Schering-Plough executives Fred Hassan and Brent Saunders named chairman and CEO, respectively. Both Hassan and Saunders left the pharmaceutical company following its merger with Merck.
Under CEO Saunders, the private eye care company will focus on three areas: contact lenses and solutions, prescription eye medicines and surgical equipment, and intraocular lenses. Bausch & Lomb faced reputation issues, following a recall for a lens solution that "was blamed for a flurry of potentially blinding fungal infections."
Matthew Herper at Forbes writes:
The job is a perfect fit. Bausch needs its manufacturing cleaned up and its brand marketing improved. Those have always been strengths for both Hassan and Saunders.